Residency · Residency · Anesthesiology

Anesthesia for Electroconvulsive Therapy (ECT)

Introduction

Electroconvulsive therapy remains one of the most effective treatments for severe, treatment-resistant depression, acute suicidality, catatonia, and certain psychotic disorders. The anesthesiologist plays a critical role in providing safe, brief general anesthesia that facilitates seizure induction while minimizing hemodynamic complications. ECT is performed as a series of treatments, typically 6 to 12 sessions over 2 to 4 weeks.

Indications for ECT

Major depressive disorder, especially when treatment-resistant, severe, or accompanied by psychotic features, is the most common indication. ECT has the most rapid onset of antidepressant efficacy, making it particularly valuable for acute suicidality. It is also used for bipolar disorder (both depressive and manic episodes), catatonia (which is often dramatically responsive), and schizophrenia with catatonic or affective features. Neuroleptic malignant syndrome may benefit from ECT when dantrolene and supportive care are insufficient. ECT is considered relatively safe during pregnancy when pharmacotherapy is inadequate or contraindicated.

Physiologic Effects of ECT

Autonomic Response

The electrical stimulus initially activates the parasympathetic nervous system, producing transient bradycardia or brief asystole lasting up to 5 to 10 seconds. This is followed by a sympathetic surge during the seizure, causing tachycardia, hypertension, and increased myocardial oxygen demand. Heart rate may reach 130 to 180 bpm, and systolic blood pressure may transiently exceed 200 mmHg. These hemodynamic swings last 5 to 10 minutes and are the primary source of morbidity.

Cerebral Effects

A generalized tonic-clonic seizure lasting ideally 25 to 60 seconds (motor seizure) or 25 to 120 seconds (EEG seizure) is induced. Cerebral blood flow and intracranial pressure increase during the seizure, and there is transient disruption of the blood-brain barrier. A seizure duration of less than 15 seconds is considered inadequate and may require stimulus adjustment.

Other Effects

Transient increases in intraocular pressure and intragastric pressure occur. Muscle contraction during the seizure can cause fractures if neuromuscular blockade is inadequate; historically, vertebral compression fractures were common before the routine use of muscle relaxants. Post-ictal confusion, headache, myalgia, and nausea are common.

Preanesthetic Assessment

Relative Contraindications

Relative contraindications include pheochromocytoma (uncontrolled catecholamine surges during ECT are dangerous), raised intracranial pressure from a space-occupying lesion with mass effect, recent cerebrovascular accident within 1 month, unstable aneurysm (cerebral or aortic), and recent myocardial infarction within 3 months. Notably, there are no absolute contraindications to ECT per APA guidelines.

Key Assessment Points

Cardiac history should address ischemic disease, arrhythmias, heart failure, and implanted cardiac devices (pacemaker, ICD). Airway assessment covers NPO status, Mallampati class, and cervical spine mobility, keeping in mind that many ECT patients are elderly. Current medications require attention: lithium prolongs neuromuscular blockade and may increase post-ictal confusion; MAOIs should be continued but meperidine must be avoided; benzodiazepines raise the seizure threshold and should be held or reduced if possible; and theophylline lowers the seizure threshold with a risk of status epilepticus. Seizure history and response to prior ECT sessions should be reviewed.

Anesthetic Technique

Setup and Equipment

Standard ASA monitors include pulse oximetry, ECG, blood pressure, and EtCO2 (if using bag-mask or LMA). EEG monitoring provided by the ECT device assesses seizure quality and duration. The isolated limb technique involves inflating a blood pressure cuff on one extremity above systolic pressure before administering succinylcholine; the unparalyzed limb allows visual assessment of motor seizure duration. Suction, airway equipment, and emergency drugs (atropine, esmolol, labetalol, nitroglycerin) should be available, along with a self-inflating bag-valve-mask with supplemental oxygen.

Induction Agents

Methohexital at 0.5 to 1.5 mg/kg IV is the traditional gold standard, offering minimal seizure threshold elevation with rapid onset and short duration. Propofol at 1 to 1.5 mg/kg IV is a widely used alternative that raises the seizure threshold and may shorten seizure duration; dose reduction compared to standard induction is recommended. Etomidate at 0.15 to 0.3 mg/kg IV has minimal effect on seizure threshold and is useful when seizure duration is inadequate with other agents, though it carries a risk of myoclonus and adrenal suppression with repeated use. Ketamine at 1 to 2 mg/kg IV may have synergistic antidepressant effects and can prolong seizure and recovery time; it is increasingly studied as an adjunct. Thiopental at 2 to 4 mg/kg IV is similar to methohexital but less widely available.

Muscle Relaxation

Succinylcholine at 0.5 to 1 mg/kg IV is the standard muscle relaxant for ECT. Its rapid onset and ultra-short duration match the brief procedure, and it provides sufficient relaxation to prevent fractures and injuries during the seizure. Contraindications include hyperkalemia, burn patients, denervation injuries, family history of malignant hyperthermia, and pseudocholinesterase deficiency. Rocuronium at 0.3 to 0.6 mg/kg IV with sugammadex reversal is an alternative for patients with contraindications to succinylcholine, though it carries higher cost and longer recovery if sugammadex is not available.

Ventilation

Preoxygenation with 100% oxygen by face mask for 2 to 3 minutes is performed before induction. Hyperventilation with bag-mask ventilation after induction and before the stimulus lowers PaCO2, which lowers seizure threshold and may improve seizure quality. Oxygenation is maintained throughout the seizure with gentle mask ventilation or passive oxygen flow. Intubation is almost never required. A bite block (rubber or gauze) is placed to protect the tongue and teeth during the stimulus.

Managing Hemodynamic Responses

For at-risk patients, the sympathetic surge can be attenuated with esmolol 0.5 to 1 mg/kg IV or labetalol 5 to 10 mg IV before the stimulus. Nitroglycerin sublingual or IV is used for severe hypertensive responses. Glycopyrrolate 0.2 mg IV or atropine 0.4 to 0.5 mg IV prevents excessive bradycardia during the parasympathetic phase but should be used selectively, not routinely. Remifentanil at 1 mcg/kg attenuates the sympathetic response but may shorten the seizure.

Seizure Quality and Troubleshooting

If seizure duration is inadequate (less than 15 seconds), the propofol dose can be reduced or the induction agent switched to methohexital or etomidate. Adequate hyperventilation before the stimulus should be ensured, and benzodiazepines should be held the morning of treatment. The psychiatrist can be asked to increase stimulus intensity, and caffeine 250 to 500 mg IV can be considered though it is rarely used. If the seizure is prolonged (greater than 120 seconds EEG or greater than 60 seconds motor), midazolam 1 to 2 mg IV or propofol 20 to 40 mg IV is administered to terminate it, as prolonged seizures increase post-ictal confusion without being more therapeutically effective.

Recovery and Post-Procedure Care

Patients are monitored in a recovery area until fully oriented. Common complaints include headache (treated with acetaminophen or ketorolac), nausea (treated with ondansetron), myalgia, and transient confusion. Short-term memory impairment is the most significant cognitive side effect of ECT and worsens with bilateral electrode placement and increasing number of treatments. Patients must have a responsible adult escort, and no driving is permitted on treatment days. Seizure duration, hemodynamic events, and any complications should be documented for each session.

Special Populations

For patients with ICDs, coordination with cardiology is needed. The ICD should be interrogated before and after ECT, and placing a magnet to disable tachyarrhythmia therapy during the procedure should be considered. Pregnant patients require left uterine displacement after 20 weeks and fetal heart rate monitoring before and after the procedure; excessive hyperventilation should be avoided as it can reduce uteroplacental blood flow. Elderly patients are often the most responsive to ECT but are at the highest risk for hemodynamic complications and cognitive effects, and induction agent doses should be reduced.

Key Clinical Pearls

ECT is a brief procedure but carries real hemodynamic risk; the transient hypertension and tachycardia can precipitate myocardial ischemia, arrhythmia, or intracranial hemorrhage in vulnerable patients. The isolated limb technique (tourniquet method) is essential for assessing motor seizure duration and should be set up before succinylcholine administration. Propofol raises the seizure threshold more than methohexital, and if seizure quality is poor, switching the induction agent is often the most effective intervention. Building a collaborative relationship with the psychiatry team is critical because ECT is a longitudinal treatment, and consistent communication about seizure quality, medication adjustments, and patient response optimizes outcomes.

References

1. Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg. 2002;94(5):1351-1364.
2. American Psychiatric Association. The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. 2nd ed. APA; 2001.
3. Mankad MV, Beyer JL, Weiner RD, Krystal AD. Clinical Manual of Electroconvulsive Therapy. 2nd ed. American Psychiatric Publishing; 2020.
4. Uppal V, Dourish J, Macfarlane A. Anaesthesia for electroconvulsive therapy. BJA Educ. 2010;10(6):192-196.

Read this lecture as Markdown